The Role of Dopamine and Glutamate Modulation in Huntington Disease

The Role of Dopamine and Glutamate Modulation in Huntington Disease

Saved in:

Bibliographic Details
Main Authors:	Sumeer K. Mittal, Clare Eddy
Format:	Article
Language:	English
Published:	Wiley 2013-01-01
Series:	Behavioural Neurology
Online Access:	http://dx.doi.org/10.3233/BEN-2012-120268
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Synaptic modulation of glutamate in striatum of the YAC128 mouse model of Huntington disease
by: Judy Cheng, et al.
Published: (2025-02-01)

Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia
by: Kunal Maini, et al.
Published: (2021-06-01)

The Role of the Immune System in Huntington’s Disease
by: Gisa Ellrichmann, et al.
Published: (2013-01-01)

deutetrabenazine for the treatment of chorea associated with Huntington’s disease
by: Harshit Gupta, et al.
Published: (2022-06-01)

Comprehensive Insight of Neurodegenerative Diseases and The Role of Neurotoxin Agents — Glutamate
by: Hui-Min Yap, et al.
Published: (2020-04-01)

Laser Evoked Potentials in Early and Presymptomatic Huntington’s Disease
by: Marina de Tommaso, et al.
Published: (2016-01-01)

Nucleic Acid-Based Therapy Approaches for Huntington's Disease
by: Tatyana Vagner, et al.
Published: (2012-01-01)

Coexistence of Gait Disturbances and Chorea in Experimental Huntington’s Disease
by: João Casaca-Carreira, et al.
Published: (2015-01-01)

Huntington’s disease modeling on HEK293 cell line
by: D. V. Sharipova, et al.
Published: (2017-12-01)

Modulation of brain glutamate dehydrogenase as a tool for controlling seizures
by: Rasgado Lourdes A. Vega, et al.
Published: (2015-12-01)

Structural Correlates of Neurological Signs in Huntington’s Disease: A Quantitative Approach
by: E. A. Loh, et al.
Published: (1994-01-01)

Glutamate Receptors in Neuroinflammatory Demyelinating Disease
Published: (2006-01-01)

A Pilot Proteomic Analysis of Huntington’s Disease by Functional Capacity
by: Andrew McGarry, et al.
Published: (2025-01-01)

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
by: Fabrizio Gasparini, et al.
Published: (2013-01-01)

Abnormalities in Glutamate Metabolism and Excitotoxicity in the Retinal Diseases
by: Makoto Ishikawa
Published: (2013-01-01)

Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington’s disease
by: Kaili Ou, et al.
Published: (2025-01-01)

Characterization of visual cognition in pre-manifest, manifest and reduced penetrance Huntington’s disease
by: Rocio Del Pino, et al.
Published: (2025-02-01)

Lipidomics of Huntington’s Disease: A Comprehensive Review of Current Status and Future Directions
by: Ali Yilmaz, et al.
Published: (2025-01-01)

Optical Coherence Tomography in Huntington's Disease—A Potential Future Biomarker for Neurodegeneration?
by: Clancy Cerejo, et al.
Published: (2025-01-01)

Pleiotropic effects of mutant huntingtin on retinopathy in two mouse models of Huntington's disease
by: Hui Xu, et al.
Published: (2025-02-01)

Psychological discomfort in carriers and non-carriers of the Huntington disease mutation and its relationship with disease burden
by: Y. Rodríguez-Agudelo, et al.
Published: (2025-01-01)

RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington’s disease models
by: Yingqi Lin, et al.
Published: (2025-01-01)

The Role of Dopamine in Impulsivity and Substance Abuse: A Narrative Review
by: Connor J Plaisance, et al.
Published: (2024-11-01)

Atypical Parkinsonism Revealing a Late Onset, Rigid and Akinetic Form of Huntington's Disease
by: A. Ciammola, et al.
Published: (2011-01-01)

From Mild Ataxia to Huntington Disease Phenocopy: The Multiple Faces of Spinocerebellar Ataxia 17
by: Georgios Koutsis, et al.
Published: (2014-01-01)

Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington’s Disease
by: Cristine de Paula Nascimento-Castro, et al.
Published: (2018-01-01)

Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient’s Perspective
by: Jesús Pérez-Pérez, et al.
Published: (2024-10-01)

Biomarkers of Oxidative Stress in Huntington's Disease and Other Neurological Disorders: a Comparative Study
by: Marisol Peña Sánchez, et al.
Published: (2023-12-01)

Mapping hippocampal glutamate in healthy aging with in vivo glutamate-weighted CEST (GluCEST) imaging
by: Maggie K. Pecsok, et al.
Published: (2025-01-01)

Predicting Disease Onset from Mutation Status Using Proband and Relative Data with Applications to Huntington's Disease
by: Tianle Chen, et al.
Published: (2012-01-01)

Correction: Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient’s Perspective
by: Jesús Pérez-Pérez, et al.
Published: (2024-11-01)

Dopamine Agonists and Pathologic Behaviors
by: Brendan J. Kelley, et al.
Published: (2012-01-01)

Immunomodulatory Effects Mediated by Dopamine
by: Rodrigo Arreola, et al.
Published: (2016-01-01)

Human striatal progenitor cells that contain inducible safeguards and overexpress BDNF rescue Huntington’s disease phenotypes
by: Danielle A. Simmons, et al.
Published: (2025-03-01)

Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s Disease
by: Daniel O. Claassen, et al.
Published: (2021-06-01)

Dopamine agonists for restless legs syndrome
by: Pran Phakdeekitcharoen, et al.
Published: (2025-02-01)

The Neurometabolic Function of the Dopamine–Aminotransferase System
by: Sergey A. Apryatin
Published: (2025-01-01)

Posttranslational Nitration of Tyrosine Residues Modulates Glutamate Transmission and Contributes to N-Methyl-D-aspartate-Mediated Thermal Hyperalgesia
by: Carolina Muscoli, et al.
Published: (2013-01-01)

Canadian healthcare capacity gaps for disease-modifying treatment in Huntington’s disease: a survey of current practice and modelling of future needs
by: Sylvain Chouinard, et al.
Published: (2022-06-01)

Compulsive Drumming Induced by Dopamine Agonists in Parkinson’s Disease: Another Aspect of Punding
by: Carmine Vitale, et al.
Published: (2013-01-01)